As the siRNA data showed that changes in RFWD3 expression can modify response to platinum, the response of RFWD3Δ/Δ cells to a range of chemotherapeutic drugs was assessed, in order to identify potential strategies to best treat tumours with differing expression of RFWD3. This evidence concerns the gene RFWD3 and neoplasm.